Income Statement MatsukiyoCocokara & Co.

Equities

3088

JP3869010003

Drug Retailers

Delayed Japan Exchange Other stock markets 06:30:00 05/12/2025 GMT			5-day change	1st Jan Change
2,832.00 ^JPY	-0.16%		-2.01%	+22.86%

11-13	MatsukiyoCocokara & Co. Announces Dividend for the Second Quarter Ended September 30, 2025, Payable on December 2, 2025 and Provides Year End Dividend Guidance for the Year Ending March 31, 2026	CI
11-13	MatsukiyoCocokara & Co. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2026	CI

b8c4.Q9UVGyAyZIESvgaHxAkuDB0GuADTB7ucGE4hIESteE4.FedNQ0RxMutkh1Ozo093QnB_7VbiNMLPbA8MEHLeSykIpSZqGWYO9CPMaQ

Published financial data: MATSUKIYOCOCOKARA & CO.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	557B	730B	951B	1,023B	1,062B
Total Revenues	557B	730B	951B	1,023B	1,062B
Cost of Goods Sold, Total	375B	490B	622B	668B	689B
Gross Profit	182B	240B	329B	354B	372B
Selling General & Admin Expenses, Total	142B	184B	246B	256B	267B
Provision for Bad Debts	12M	-	-	54M	-
Depreciation & Amortization - (IS)	7.74B	11.05B	14.24B	15.71B	16.05B
Amortization of Goodwill and Intangible Assets - (IS)	840M	3.81B	6.58B	6.58B	6.48B
Other Operating Expenses	11M	11M	-13M	8M	157M
Other Operating Expenses, Total	151B	199B	267B	278B	290B
Operating Income	31.52B	41.41B	62.28B	75.65B	82.08B
Interest Expense, Total	-44M	-60M	-53M	-57M	-64M
Interest And Investment Income	497M	519M	568M	619M	616M
Net Interest Expenses	453M	459M	515M	562M	552M
Income (Loss) On Equity Invest.	-	-304M	-	-	-
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	2.12B	3.32B	3.93B	4.28B	3.63B
EBT, Excl. Unusual Items	34.09B	44.88B	66.72B	80.5B	86.27B
Gain (Loss) On Sale Of Investments	354M	10.48B	-69M	2.74B	8M
Gain (Loss) On Sale Of Assets	20M	-36M	647M	-41M	527M
Asset Writedown	-602M	-4.88B	-1.9B	-2.38B	-2.72B
Other Unusual Items	-1.25B	-817M	-493M	424M	-195M
EBT, Incl. Unusual Items	32.62B	49.63B	64.91B	81.24B	83.89B
Income Tax Expense	11.05B	15.02B	24.14B	28.63B	28.88B
Earnings From Continuing Operations	21.57B	34.61B	40.76B	52.62B	55.01B
Net Income to Company	21.57B	34.61B	40.76B	52.62B	55.01B
Minority Interest	-	-24M	-220M	-268M	-334M
Net Income - (IS)	21.57B	34.59B	40.54B	52.35B	54.68B
Net Income to Common Incl Extra Items	21.57B	34.59B	40.54B	52.35B	54.68B
Net Income to Common Excl. Extra Items	21.57B	34.59B	40.54B	52.35B	54.68B
Per Share Items
Net EPS - Basic	70.04	94.38	96.02	125.31	133.85
Basic EPS - Continuing Operations	70.04	94.38	96.02	125.31	133.85
Basic Weighted Average Shares Outstanding	308M	366M	422M	418M	408M
Net EPS - Diluted	70.01	94.35	95.99	125.28	133.81
Diluted EPS - Continuing Operations	70.01	94.35	95.99	125.28	133.81
Diluted Weighted Average Shares Outstanding	308M	367M	422M	418M	409M
Normalized Basic EPS	69.19	76.48	98.23	119.79	131.18
Normalized Diluted EPS	69.16	76.45	98.2	119.76	131.14
Dividend Per Share	23.33	23.33	23.33	37	44
Payout Ratio	33.35	23.92	26.09	25.32	30.78
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	40.1B	56.27B	83.12B	98.02B	105B
EBITA	32.36B	45.22B	68.85B	82.24B	88.56B
EBIT	31.52B	41.41B	62.28B	75.65B	82.08B
EBITDAR	76.33B	108B	150B	169B	179B
Effective Tax Rate - (Ratio)	33.87	30.26	37.19	35.24	34.43
Normalized Net Income	21.31B	28.03B	41.48B	50.04B	53.58B
Non-Cash Pension Expense	36M	120M	133M	66M	37M
Supplemental Operating Expense Items
Advertising Expense	1.4B	1.69B	2.13B	2.25B	2.18B
Selling and Marketing Expenses	1.4B	1.69B	2.13B	2.25B	2.18B
Net Rental Expense, Total	36.23B	51.39B	67.26B	71.16B	74.34B
Imputed Operating Lease Interest Expense	532M	1.06B	1.29B	1.54B	3.33B
Imputed Operating Lease Depreciation	35.69B	50.33B	65.98B	69.61B	71.01B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	38.52B	74.52B	95.22B	118B	112B
Total Cash And Short Term Investments	38.52B	74.52B	95.22B	118B	112B
Accounts Receivable, Total	27.36B	51.8B	55.43B	61.72B	64.4B
Other Receivables	18.69B	29.07B	32.42B	37.79B	31.32B
Total Receivables	46.05B	80.87B	87.85B	99.51B	95.72B
Inventory	86.44B	138B	136B	139B	145B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	4.69B	11.04B	10.26B	14.21B	11.63B
Total Current Assets	176B	304B	330B	371B	364B
Net Property Plant And Equipment	72.79B	107B	110B	114B	111B
Long-term Investments	106B	86.61B	95.55B	93.62B	95.73B
Goodwill	4.03B	119B	113B	106B	99.26B
Other Intangibles, Total	4.86B	24.32B	24.83B	27.47B	28.78B
Deferred Tax Assets Long-Term	5.35B	15.25B	15.15B	13.45B	13.82B
Other Long-Term Assets, Total	2M	2M	2M	1M	2M
Total Assets	369B	657B	688B	725B	713B
Liabilities
Accounts Payable, Total	55.52B	92.5B	102B	106B	108B
Accrued Expenses, Total	3.87B	5.71B	6.24B	5.6B	5.75B
Short-term Borrowings	-	884M	995M	970M	1.19B
Current Portion of Long-Term Debt	-	-	-	18.4B	-
Current Portion of Leases	1.98B	1.76B	1.12B	705M	411M
Current Income Taxes Payable	5.66B	11.54B	14.28B	17.39B	16.61B
Other Current Liabilities	17.86B	30.06B	28.19B	30.28B	30.5B
Total Current Liabilities	84.89B	142B	153B	179B	163B
Long-Term Debt	18.4B	18.4B	18.4B	-	-
Long-Term Leases	3.32B	1.88B	898M	588M	607M
Pension & Other Post Retirement Benefits	282M	5.93B	5.9B	396M	31M
Deferred Tax Liability Non Current	4.43B	9.54B	11.66B	8.9B	8.62B
Other Non Current Liabilities	11.14B	14.19B	15.29B	20.26B	19.38B
Total Liabilities	122B	192B	205B	210B	191B
Common Stock, Total	22.05B	22.05B	22.05B	22.05B	22.05B
Additional Paid In Capital	23B	206B	206B	206B	179B
Retained Earnings	211B	236B	262B	301B	339B
Treasury Stock	-20.68B	-6.44B	-18.09B	-21.35B	-24.95B
Comprehensive Income and Other	11.46B	6.5B	10.54B	6.83B	5.87B
Total Common Equity	246B	464B	482B	515B	521B
Minority Interest	-	24M	245M	447M	701M
Total Equity	246B	464B	483B	515B	521B
Total Liabilities And Equity	369B	657B	688B	725B	713B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	306M	424M	418M	417M	404M
ECS Total Common Shares Outstanding	308M	424M	418M	417M	404M
Book Value / Share	800.3	1.1K	1.15K	1.23K	1.29K
Tangible Book Value	238B	321B	345B	382B	393B
Tangible Book Value Per Share	771.42	756.97	823.81	914.61	973.22
Total Debt	23.7B	22.92B	21.41B	20.66B	2.2B
Net Debt	-14.82B	-51.6B	-73.81B	-97.06B	-110B
Debt Equivalent of Unfunded Proj. Benefit Obligation	282M	5.93B	5.9B	396M	31M
Debt Equivalent Oper. Leases	290B	411B	538B	569B	595B
Minority Interest, Total (Incl. Fin. Div)	-	24M	245M	447M	701M
Inventories - Raw Materials, Total	655M	683M	543M	779M	1.05B
Inventories - Finished Goods, Total	85.79B	137B	136B	139B	144B
Full Time Employees	6.69K	13.32K	13.66K	13.37K	12.75K
Accumulated Allowance for Doubtful Accounts (Supple)	62M	48M	36M	24M	70M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	32.62B	49.63B	64.91B	81.25B	83.89B
Depreciation & Amortization - CF	7.74B	11.05B	14.26B	15.78B	16.12B
Amortization of Goodwill and Intangible Assets - (CF)	840M	3.81B	6.58B	6.58B	6.48B
Depreciation & Amortization, Total	8.58B	14.86B	20.84B	22.37B	22.6B
(Gain) Loss From Sale Of Asset	586M	4.92B	1.25B	2.42B	2.19B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-2.74B	-7M
Other Operating Activities, Total	-10.77B	-13.13B	-20.35B	-28.56B	-21.32B
Change In Accounts Receivable	-3.94B	-807M	-3.4B	-6.26B	-2.71B
Change In Inventories	-4.54B	-466M	-4.6B	-2.8B	-5.82B
Change In Accounts Payable	-1.71B	-2.26B	9.22B	6.4B	1.03B
Change in Other Net Operating Assets	5.05B	-12.94B	-3.81B	-8.56B	1.61B
Cash from Operations	25.88B	39.81B	64.06B	63.51B	81.47B
Capital Expenditure	-3.63B	-9.32B	-13.59B	-13.21B	-8.83B
Sale of Property, Plant, and Equipment	-	-	1.85B	735M	1.62B
Cash Acquisitions	-275M	-1.5B	-93M	-4.22B	-5B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.64B	-1.65B	-3.15B	-6.9B	-5.62B
Investment in Marketable and Equity Securities, Total	459M	86M	-	4.73B	186M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-70M	-1.23B	-3M	-318M
Other Investing Activities, Total	-1.23B	-3.04B	-3.46B	-3.88B	-2.83B
Cash from Investing	-6.31B	-15.48B	-19.67B	-22.76B	-20.79B
Short Term Debt Issued, Total	-	-	264M	-	347M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	264M	-	347M
Short Term Debt Repaid, Total	-	-574M	-	-91M	-
Long-Term Debt Repaid, Total	-	-419M	-	-	-18.4B
Total Debt Repaid	-	-993M	-	-91M	-18.4B
Issuance of Common Stock	-	-	157M	10M	28M
Repurchase of Common Stock	-	-9.01B	-11.86B	-3.69B	-30.95B
Common Dividends Paid	-7.19B	-8.27B	-10.58B	-13.25B	-16.83B
Common & Preferred Stock Dividends Paid	-7.19B	-8.27B	-10.58B	-13.25B	-16.83B
Other Financing Activities, Total	-2.22B	-2.06B	-1.72B	-1.25B	-853M
Cash from Financing	-9.41B	-20.34B	-23.73B	-18.27B	-66.66B
Foreign Exchange Rate Adjustments	-	-	-30M	23M	12M
Miscellaneous Cash Flow Adjustments	-2M	32.01B	77M	-1M	-
Net Change in Cash	10.15B	36B	20.7B	22.5B	-5.97B
Supplemental Items
Cash Interest Paid	44M	60M	53M	57M	60M
Cash Income Tax Paid (Refund)	11.26B	13.3B	20.22B	28.43B	21.24B
Levered Free Cash Flow	16.17B	-6.05B	49.62B	39.2B	61.6B
Unlevered Free Cash Flow	16.2B	-6.01B	49.65B	39.24B	61.64B
Change In Net Working Capital	6.81B	35.79B	-6.63B	10.3B	-2.2B
Net Debt Issued / Repaid	-	-993M	264M	-91M	-18.05B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.47	5.05	5.79	6.69	7.14
Return on Total Capital	7.52	6.83	7.85	9.09	9.68
Return On Equity %	9.07	9.74	8.61	10.55	10.61
Return on Common Equity	9.07	9.73	8.56	10.5	10.56
Margin Analysis
Gross Profit Margin %	32.7	32.92	34.62	34.63	35.06
SG&A Margin	25.49	25.21	25.89	25.04	25.19
EBITDA Margin %	7.2	7.71	8.74	9.59	9.86
EBITA Margin %	5.81	6.19	7.24	8.04	8.34
EBIT Margin %	5.66	5.67	6.55	7.4	7.73
Income From Continuing Operations Margin %	3.87	4.74	4.29	5.15	5.18
Net Income Margin %	3.87	4.74	4.26	5.12	5.15
Net Avail. For Common Margin %	3.87	4.74	4.26	5.12	5.15
Normalized Net Income Margin	3.83	3.84	4.36	4.89	5.05
Levered Free Cash Flow Margin	2.9	-0.83	5.22	3.83	5.8
Unlevered Free Cash Flow Margin	2.91	-0.82	5.22	3.84	5.81
Asset Turnover
Asset Turnover	1.55	1.42	1.41	1.45	1.48
Fixed Assets Turnover	7.58	8.11	8.78	9.16	9.46
Receivables Turnover (Average Receivables)	21.92	18.44	17.74	17.46	16.83
Inventory Turnover (Average Inventory)	4.45	4.36	4.53	4.85	4.85
Short Term Liquidity
Current Ratio	2.07	2.14	2.15	2.07	2.24
Quick Ratio	1	1.09	1.19	1.21	1.28
Operating Cash Flow to Current Liabilities	0.3	0.28	0.42	0.35	0.5
Days Sales Outstanding (Average Receivables)	16.65	19.79	20.57	20.97	21.68
Days Outstanding Inventory (Average Inventory)	81.97	83.63	80.53	75.52	75.33
Average Days Payable Outstanding	54.35	49.91	57.34	56.84	56.24
Cash Conversion Cycle (Average Days)	44.27	53.51	43.77	39.64	40.77
Long Term Solvency
Total Debt/Equity	9.62	4.94	4.44	4.01	0.42
Total Debt / Total Capital	8.77	4.7	4.25	3.86	0.42
LT Debt/Equity	8.81	4.37	4	0.11	0.12
Long-Term Debt / Total Capital	8.04	4.16	3.83	0.11	0.12
Total Liabilities / Total Assets	33.19	29.3	29.85	28.92	26.84
EBIT / Interest Expense	716.41	690.13	1.18K	1.33K	1.28K
EBITDA / Interest Expense	911.36	937.82	1.57K	1.72K	1.64K
(EBITDA - Capex) / Interest Expense	828.86	782.53	1.31K	1.49K	1.5K
Total Debt / EBITDA	0.59	0.41	0.26	0.21	0.02
Net Debt / EBITDA	-0.37	-0.92	-0.89	-0.99	-1.05
Total Debt / (EBITDA - Capex)	0.65	0.49	0.31	0.24	0.02
Net Debt / (EBITDA - Capex)	-0.41	-1.1	-1.06	-1.14	-1.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.7	31.08	30.31	7.49	3.82
Gross Profit, 1 Yr. Growth %	-3.88	31.96	37.05	7.52	5.12
EBITDA, 1 Yr. Growth %	-12.74	40.32	47.71	17.93	6.8
EBITA, 1 Yr. Growth %	-15.85	39.72	52.27	19.44	7.69
EBIT, 1 Yr. Growth %	-16.06	31.36	50.4	21.48	8.5
Earnings From Cont. Operations, 1 Yr. Growth %	-17.6	60.48	17.78	29.07	4.55
Net Income, 1 Yr. Growth %	-17.6	60.37	17.22	29.11	4.45
Normalized Net Income, 1 Yr. Growth %	-14.74	31.54	48	20.64	7.08
Diluted EPS Before Extra, 1 Yr. Growth %	-17.62	34.77	1.74	30.51	6.81
Accounts Receivable, 1 Yr. Growth %	16.65	89.38	7.01	11.34	4.34
Inventory, 1 Yr. Growth %	5.54	59.6	-1.07	2.1	4.21
Net Property, Plant and Equip., 1 Yr. Growth %	-1.76	47.17	2.38	3.64	-2.45
Total Assets, 1 Yr. Growth %	4.86	78.01	4.78	5.32	-1.65
Tangible Book Value, 1 Yr. Growth %	8.04	35.1	7.34	10.74	2.95
Common Equity, 1 Yr. Growth %	7.48	88.39	3.91	6.69	1.18
Cash From Operations, 1 Yr. Growth %	4.49	53.86	60.91	-0.87	28.29
Capital Expenditures, 1 Yr. Growth %	-19.71	156.67	45.91	-2.83	-33.12
Levered Free Cash Flow, 1 Yr. Growth %	17.01	-137.4	-920.29	-20.98	57.14
Unlevered Free Cash Flow, 1 Yr. Growth %	17.12	-137.1	-925.95	-20.96	57.1
Dividend Per Share, 1 Yr. Growth %	0	0	0	58.57	18.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.67	11.18	30.69	18.35	5.64
Gross Profit, 2 Yr. CAGR %	0.73	12.63	34.48	21.39	6.32
EBITDA, 2 Yr. CAGR %	-4.82	10.65	43.97	31.98	12.23
EBITA, 2 Yr. CAGR %	-6.43	8.43	45.86	34.86	13.41
EBIT, 2 Yr. CAGR %	-6.46	5.01	40.56	35.17	14.81
Earnings From Cont. Operations, 2 Yr. CAGR %	-7.18	14.99	37.48	23.29	16.16
Net Income, 2 Yr. CAGR %	-7.18	14.95	37.11	23.02	16.12
Normalized Net Income, 2 Yr. CAGR %	-6.48	5.9	39.53	33.63	13.66
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.32	5.37	17.1	15.23	18.07
Accounts Receivable, 2 Yr. CAGR %	7.97	48.63	42.35	9.15	7.78
Inventory, 2 Yr. CAGR %	6.08	29.78	25.65	0.5	3.15
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.39	20.24	22.75	3.01	0.55
Total Assets, 2 Yr. CAGR %	7.65	36.63	36.57	5.05	1.78
Tangible Book Value, 2 Yr. CAGR %	9.16	20.81	20.42	9.03	6.77
Common Equity, 2 Yr. CAGR %	8.52	42.3	39.91	5.29	3.9
Cash From Operations, 2 Yr. CAGR %	8.7	26.79	57.35	26.3	12.77
Capital Expenditures, 2 Yr. CAGR %	-11.15	43.56	93.52	19.07	-19.39
Levered Free Cash Flow, 2 Yr. CAGR %	3.38	-33.85	75.15	154.59	11.43
Unlevered Free Cash Flow, 2 Yr. CAGR %	3.43	-34.08	75.06	155.5	11.43
Dividend Per Share, 2 Yr. CAGR %	3.77	0	0	25.93	37.32
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.12	8.22	17.22	22.45	13.3
Gross Profit, 3 Yr. CAGR %	2.48	10.22	20.24	24.82	15.71
EBITDA, 3 Yr. CAGR %	-0.95	8.33	21.84	34.71	22.99
EBITA, 3 Yr. CAGR %	-2.32	6.95	21.43	36.46	25.12
EBIT, 3 Yr. CAGR %	-2.07	4.75	18.37	33.89	25.62
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.77	11.4	15.91	34.62	16.7
Net Income, 3 Yr. CAGR %	-1.77	11.38	15.7	34.39	16.49
Normalized Net Income, 3 Yr. CAGR %	-1.91	4.78	18.4	32.92	24.12
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.76	5.75	4.15	21.41	12.35
Accounts Receivable, 3 Yr. CAGR %	9.39	30.21	33.21	31.16	7.52
Inventory, 3 Yr. CAGR %	7.1	21.55	18.56	17.25	1.72
Net Property, Plant and Equip., 3 Yr. CAGR %	0.44	13.45	13.96	16.02	1.15
Total Assets, 3 Yr. CAGR %	5.39	27.3	25.06	25.24	2.77
Tangible Book Value, 3 Yr. CAGR %	7.01	17.2	16.14	17.1	6.96
Common Equity, 3 Yr. CAGR %	6.35	30.43	28.14	27.82	3.9
Cash From Operations, 3 Yr. CAGR %	-2.52	22.05	37.27	34.89	26.96
Capital Expenditures, 3 Yr. CAGR %	2.17	26.54	44.33	53.81	-1.76
Levered Free Cash Flow, 3 Yr. CAGR %	-6.43	-26.34	53.11	34.33	116.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.39	-26.51	53.11	34.29	117.26
Dividend Per Share, 3 Yr. CAGR %	8.37	2.5	0	16.61	23.55
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.77	6.41	11.22	12.16	12.44
Gross Profit, 5 Yr. CAGR %	3.19	8.71	14.25	14.56	14.46
EBITDA, 5 Yr. CAGR %	2.76	9.12	15.03	17.23	17.9
EBITA, 5 Yr. CAGR %	2.42	8.84	14.67	17.34	18.15
EBIT, 5 Yr. CAGR %	2.83	7.81	13.16	15.99	16.93
Earnings From Cont. Operations, 5 Yr. CAGR %	3.83	11.46	12.37	16.01	16.01
Net Income, 5 Yr. CAGR %	3.85	11.45	12.25	15.9	15.87
Normalized Net Income, 5 Yr. CAGR %	2.74	7.78	12.94	15.49	16.48
Diluted EPS Before Extra, 5 Yr. CAGR %	4.77	8.42	6.03	9.45	9.51
Accounts Receivable, 5 Yr. CAGR %	8.67	23.79	21.54	21.34	22.39
Inventory, 5 Yr. CAGR %	5.76	15.29	14.17	12.65	12.14
Net Property, Plant and Equip., 5 Yr. CAGR %	0.22	8.49	8.83	9.15	8.4
Total Assets, 5 Yr. CAGR %	5.9	18.11	16.9	17.89	15.17
Tangible Book Value, 5 Yr. CAGR %	8.35	13.28	12.19	13.86	12.3
Common Equity, 5 Yr. CAGR %	7.5	20.33	18.69	19.72	17.83
Cash From Operations, 5 Yr. CAGR %	-3.6	10.91	18.05	23.73	26.89
Capital Expenditures, 5 Yr. CAGR %	-6.47	20.36	31.91	23.5	14.34
Levered Free Cash Flow, 5 Yr. CAGR %	-8.3	-14.9	20.24	20.97	34.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.28	-15.02	20.24	20.97	34.83
Dividend Per Share, 5 Yr. CAGR %	10.49	8.06	4.94	11.3	13.53